ACTOGENIX
ActoGeniX is a biopharmaceutical company focused on the development and commercialization of a range of biological drugs. ActoGeniX was founded by Bernard Coulie and Mark Vaeck in 2006 and is based in Zwijnaarde, Belgium.
ACTOGENIX
Industry:
Biopharma Biotechnology Clinical Trials Pharmaceutical
Founded:
2006-01-01
Address:
Zwijnaarde, Oost-Vlaanderen, Belgium
Country:
Belgium
Website Url:
http://www.actogenix.com
Total Employee:
251+
Status:
Closed
Contact:
32 9 261 06 00
Total Funding:
46.98 M USD
Technology used in webpage:
Belgian Server Location
Current Advisors List
Current Employees Featured
Founder
Investors List
Biotech Fund Flanders
Biotech Fund Flanders investment in Private Equity Round - ActoGeniX
VIB
VIB investment in Private Equity Round - ActoGeniX
Ventech
Ventech investment in Private Equity Round - ActoGeniX
EQT Life Sciences
EQT Life Sciences investment in Private Equity Round - ActoGeniX
Gimv
Gimv investment in Private Equity Round - ActoGeniX
Aescap Venture
Aescap Venture investment in Private Equity Round - ActoGeniX
Baekeland Funds
Baekeland Funds investment in Private Equity Round - ActoGeniX
Aescap Venture
Aescap Venture investment in Venture Round - ActoGeniX
Gimv
Gimv investment in Venture Round - ActoGeniX
EQT Life Sciences
EQT Life Sciences investment in Venture Round - ActoGeniX
Official Site Inspections
http://www.actogenix.com
- Host name: 172.67.169.250
- IP address: 172.67.169.250
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "ActoGeniX"
ActoGeniX - Crunchbase Company Profile & Funding
A biopharmaceutical company, focused on the development and โฆSee details»
ActoGeniX ActoGeniX ActoGeniX - Gimv
Feb 13, 2015 ActoGeniX was founded in June 2006 as a spin-off of the Flemish Institute for Biotechnology (VIB) and the University of Ghent. ActoGeniX โฆSee details»
Home - Aptogenix
What makes Aptogenix different from other competitors? Aptogenix is a professional-grade nutraceutical company, meaning we hold our ingredients, manufacturing process, distribution โฆSee details»
Actogenix - VentureRadar
"ActoGeniX was founded in June 2006 as a spin-off from VIB and Ghent University, to apply its proprietary TopAct platform for the development of novel biopharmaceuticals. TopAct is a โฆSee details»
ActoGeniX 2025 Company Profile: Valuation, Investors ... - PitchBook
Information on acquisition, funding, cap tables, investors, and executives for ActoGeniX. Use the PitchBook Platform to explore the full profile.See details»
ActoGeniX N.V. | LinkedIn
ActoGeniX N.V. | 931 followers on LinkedIn. ActoGeniX is a biopharmaceutical company, focused on the development and commercialization of a new generation of biological drugs; ActoBiotics ...See details»
ActoGeniX - 2025 Company Profile, Funding & Competitors - Tracxn
May 5, 2025 ActoGeniX - Engineering microbes for in situ expression and secretion of novel biotherapeutic proteins and peptides.. Acquired by Precigen. Raised a total funding of $57.2M โฆSee details»
ActoGeniX - Products, Competitors, Financials, Employees, โฆ
About ActoGeniX ActoGeniX is a biopharmaceutical company, focused on the development and commercialization of a new generation of biological drugs; ActoBiotics. ActoGeniX's mission is โฆSee details»
ActoGeniX - EverybodyWiki Bios & Wiki
Apr 19, 2017 ActoGeniX is a biopharmaceutical company, based in Ghent, Belgium, focused on the development and commercialization of ActoBioticsโข, a novel class of orally available โฆSee details»
ActoGeniX (Intrexon)
Do You Want to Know More? We are eager to explore how we can achieve great things together.See details»
Apogenix ว Immuno-oncology therapeutics for the treatment of โฆ
Apogenix develops innovative protein therapeutics for the treatment of cancer and other malignant diseases. Our lead drug candidate APG101 has demonstrated a statistically significant โฆSee details»
Intrexon Acquires ActoGeniX for $60M - genengnews.com
Feb 13, 2015 Intrexon said today it will acquire ActoGeniX for $60 million, in a deal that combines the companiesโ technologies to create new oral biologic drugs for a variety of โฆSee details»
About - Aptogenix
We designed Aptogenix using data collected from tens of thousands of patient cases and outcomes over the past five (5) years. Our core protocols were created with optimal delivery โฆSee details»
Home [www.actgenix.com]
Connecting with the right business partners, can dynamically align and activate shared resouces to accelerate time-to-value strategic imperatives and breakthroughs.See details»
Synthetic Biology Company Intrexon To Acquire ActoGeniX
Feb 17, 2015 Intrexon Corporation, a Germantown, Maryland-based company specializing in synthetic biology, has agreed to acquire ActoGeniX, a clinical-stage biopharmaceutical โฆSee details»
Actogenix | VentureRadar
ActoGeniX was founded in June 2006 as a spin-off from VIB and Ghent University, to apply its proprietary TopAct platform for the development of novel biopharmaceuticals. TopAct is a โฆSee details»
Intrexon to acquire ActoGeniX in US$60m deal
Feb 16, 2015 Intrexon, a US specialist in synthetic biology, is to acquire ActoGeniX, a Belgian biotech company, to 'forge a new frontier in cellular therapeutics'. Under the US$60m deal, โฆSee details»
Subscriptions - Aptogenix
Introducing our latest game-changing feature โ subscriptions are now available in our Aptogenix ordering portal! Simplify your ordering workflow, ensure consistent product availability, and โฆSee details»
Login - Aptogenix
Welcome to Aptogenix Provider Portal The premier supplement ordering system. Log in below to access your client list and ordering platform.See details»
Login - Aptogenix
Welcome to Aptogenix Shop The premier supplement ordering system. Log in below to access your account.See details»